NegativeReview/Other2005
Daily cannabis smoking as a risk factor for progression of fibrosis in chronic hepatitis C.
Classification Results
AI Classification
NegativeFine-tuned Classification
N/AAI Classification
NegativeFine-tuned Classification
N/AAção terapêutica do canabidiol (cannabis sativa l.) na esteatose hepática
Medical cannabis for chronic pain management: questions and answers between clinical and medico-legal issues
Chronic administration of a cannabis-derived mixture at an antihyperalgesic dose does not significantly enhance hepatotoxicity or the development of metabolic dysfunction-associated steatohepatitis in male mice
Examining Silybum Marianum As A Natural Countermeasure To 1,4-Dioxane Induced Hemato-, Hepato- And Nephrotoxicity In Male Sprague-Dawley Rats
Targeting cannabinoid receptor 1 for antagonism in pro-fibrotic alveolar macrophages mitigates pulmonary fibrosis
Effects of five cannabis oils with different CBD: THC ratios and terpenes on hypertension, dyslipidemia, hepatic steatosis, oxidative stress, and CB1 receptor in an experimental model